Crossbow Therapeutics
Crossbow Therapeutics is a biotech company in Cambridge, United States, founded in 2023. It has raised $157.0M across 2 rounds, most recently a $77.0M Series B in March 2026.
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2023
- Business Model
- B2B
- Website
- crossbowtherapeutics.com
- Total Funding
- $157.0M
- Last Round
- $77.0M Series BMar 2026
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.
About
Biotech developing T-cell engager bispecific antibodies (T-Bolts) for cancer immunotherapy; Phase 1 trial ongoing.
Summary
It lists 11–50 employees. It has raised $157.0M in total across 2 rounds, most recently a $77.0M Series B round in Mar 2026. Investors include MPM BioImpact and Pfizer Ventures.
Funding History
Mar 2026
Sign up to see all 2 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/crossbow-therapeutics"><img src="https://indexed.vc/api/badge/company/crossbow-therapeutics" alt="Crossbow Therapeutics on Indexed.vc" width="260" height="76" /></a>